590 related articles for article (PubMed ID: 11435613)
21. Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells.
Wu G; Fan RS; Li W; Ko TC; Brattain MG
Oncogene; 1997 Sep; 15(13):1555-63. PubMed ID: 9380407
[TBL] [Abstract][Full Text] [Related]
22. The induction of apoptosis by a combined 1,25(OH)2D3 analog, EB1089 and TGF-beta1 in NCI-H929 multiple myeloma cells.
Park WH; Seol JG; Kim ES; Binderup L; Koeffler HP; Kim BK; Lee YY
Int J Oncol; 2002 Mar; 20(3):533-42. PubMed ID: 11836565
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray.
Swami S; Raghavachari N; Muller UR; Bao YP; Feldman D
Breast Cancer Res Treat; 2003 Jul; 80(1):49-62. PubMed ID: 12889598
[TBL] [Abstract][Full Text] [Related]
24. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
25. Effect of a novel vitamin D3 analog, EB1089, on G1 cell cycle regulatory proteins in HL-60 cells.
Seol JG; Park WH; Kim ES; Jung CW; Binderup L; Koeffler HP; Kim BK; Lee YY
Int J Oncol; 2000 Feb; 16(2):315-20. PubMed ID: 10639575
[TBL] [Abstract][Full Text] [Related]
26. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
Lu HQ; Zheng J
Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369
[TBL] [Abstract][Full Text] [Related]
27. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells.
Khanim FL; Gommersall LM; Wood VH; Smith KL; Montalvo L; O'Neill LP; Xu Y; Peehl DM; Stewart PM; Turner BM; Campbell MJ
Oncogene; 2004 Sep; 23(40):6712-25. PubMed ID: 15300237
[TBL] [Abstract][Full Text] [Related]
28. A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1.
Scaglione-Sewell BA; Bissonnette M; Skarosi S; Abraham C; Brasitus TA
Endocrinology; 2000 Nov; 141(11):3931-9. PubMed ID: 11089522
[TBL] [Abstract][Full Text] [Related]
29. Correlation between induction of the mac25 gene and anti-proliferative effects of 1alpha,25(OH)2-D3 on breast cancer and leukemic cells.
Kanemitsu N; Kato MV; Bai F; Miki T; Inoue T; Sakai T
Int J Mol Med; 2001 May; 7(5):515-20. PubMed ID: 11295114
[TBL] [Abstract][Full Text] [Related]
30. Growth inhibitory effects of 1alpha, 25-dihydroxyvitamin D(3) are mediated by increased levels of p21 in the prostatic carcinoma cell line ALVA-31.
Moffatt KA; Johannes WU; Hedlund TE; Miller GJ
Cancer Res; 2001 Oct; 61(19):7122-9. PubMed ID: 11585744
[TBL] [Abstract][Full Text] [Related]
31. Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.
Alagbala AA; Johnson CS; Trump DL; Posner GH; Foster BA
Oncology; 2006; 70(6):483-92. PubMed ID: 17237623
[TBL] [Abstract][Full Text] [Related]
32. 1α,25-dihydroxyvitamin D3 modulates CYP2R1 gene expression in human oral squamous cell carcinoma tumor cells.
Sundaram K; Sambandam Y; Tsuruga E; Wagner CL; Reddy SV
Horm Cancer; 2014 Apr; 5(2):90-7. PubMed ID: 24497297
[TBL] [Abstract][Full Text] [Related]
33. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
[TBL] [Abstract][Full Text] [Related]
34. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
35. Cell cycle arrest and apoptosis induced by 1α,25(OH)2D3 and TX 527 in Kaposi sarcoma is VDR dependent.
González-Pardo V; Suares A; Verstuyf A; De Clercq P; Boland R; de Boland AR
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():197-200. PubMed ID: 24316429
[TBL] [Abstract][Full Text] [Related]
36. Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089.
Zhang X; Jiang F; Li P; Li C; Ma Q; Nicosia SV; Bai W
Clin Cancer Res; 2005 Jan; 11(1):323-8. PubMed ID: 15671562
[TBL] [Abstract][Full Text] [Related]
37. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
38. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG
J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery.
Jensen SS; Madsen MW; Lukas J; Binderup L; Bartek J
Mol Endocrinol; 2001 Aug; 15(8):1370-80. PubMed ID: 11463860
[TBL] [Abstract][Full Text] [Related]
40. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3.
Miura D; Manabe K; Ozono K; Saito M; Gao Q; Norman AW; Ishizuka S
J Biol Chem; 1999 Jun; 274(23):16392-9. PubMed ID: 10347199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
